Sotac Pharmaceuticals Ltd (NSE SME)

User profile picture

Sotac Pharmaceuticals Ltd (NSE SME)

March 29, 2023 – April 3, 2023

Price ₹105 - ₹111
Premium
Lot size 1200
Allotment Apr 10, 2023
Listing Apr 13, 2023

Address

Sotac Pharmaceuticals Limited
Plot No. PF-21, Nr. ACME Pharma,
Opp. Teva Pharma Sanand GIDC-II,
Sanand Ahmedabad - 382110
Phone: +91 90819 93300
Email: compliance@sotacpharma.com
Website: http://www.sotacpharma.com/

Registrar
Kfin Technologies Limited
Address: Kfin Technologies Limited KFintech, Tower-B, Plot No 31 & 32, Financial District, Nanakramguda, Gachibowli, Hyderabad, Telangana India - 500 032.
Subscription
Investor CategorySubscription (times)
Qualified Institutions1.00
Non-Institutional Buyers4.04
Retail Investors0.91
Employees[.]
Others[.]
Total1.60
About
Category Lot(s) Qty Amount Reserved
Retail 1 1200 133200 0
HNI 2 2400 266400 0

Incorporated in 2015, Sotac Pharmaceuticals Limited is a part of the SOTAC group, based in Gujarat. The company is in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis. The company's business is majorly on principle to principle basis with different marketers.

SOTAC is serving over 162 corporate clients on a loan license and/or contract manufacturing basis. With their vast experience in the pharmaceutical segment, the company is growing and enlarging its scale of operations every year.

Sotac Pharmaceuticals established its manufacturing facility in the year 2017. In the year, the company's manufacturing facility was installed with the capacity to manufacture 90 Crore tables/year, and 14 Crore Capsules/year.

With a combined experience of over 59 years in the pharmaceutical manufacturing Industry of the Promoters, the company is blooming and expanding in various horizons.

Sotac Pharmaceuticals IPO Details
Total Issue Size3,000,000 shares
(aggregating up to ₹33.30 Cr)
Fresh Issue3,000,000 shares
(aggregating up to ₹[.] Cr)
Issue TypeBook Built Issue IPO
Listing AtNSE SME
Sotac Pharmaceuticals IPO Reservation
QIB Shares OfferedNot more than 50% of the Net Issue
NII (HNI) Shares OfferedNot less than 15% of the Net Issue
Retail Shares OfferedNot less than 35% of the Net Issue
Market Maker portion150,000 shares (SUNFLOWER BROKING PVT. LTD.)
Company Financials
Sotac Pharmaceuticals Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-203,038.212,882.648.75305.7375.7315.13
31-Mar-213,469.754,894.97-236.54249.3619.361,035.80
31-Mar-223,525.357,337.02287.86662.19432.191,134.59
30-Sep-226,461.603,994.6546.55797.41567.412,185.52
Amount in ₹ Lakhs

Strength

Weakness